Abstract
Rights: UNKNOWN · https://www.elsevier.com/tdm/userlicense/1.0/ · Source: journal-auto-sync:external:CROSSREF_ISSN
M Partridge, S Kiguwa, G Emilion, S Pateromichelakis, R A'Hern, J.D Langdon
Abstract
Rights: UNKNOWN · https://www.elsevier.com/tdm/userlicense/1.0/ · Source: journal-auto-sync:external:CROSSREF_ISSN
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Implications of the p53 tumour suppressor gene in clinical oncology
10.1200/jco.1995.13.4.1009 · 1995
Expression of the tumour suppressor gene p53 in oral cancer
10.1016/0266-4356(92)90263-i · 1992
Expression of p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions
10.1111/j.1600-0714.1992.tb01028.x · 1992
Over-expression of p53 in head and neck cancer
10.1002/hed.2880140603 · 1992
Assessment of p53 protein expression in normal, benign and malignant oral mucosa
10.1002/path.1711660411 · 1992
Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck
10.1038/bjc.1991.352 · 1991
Sequential p53 mutation analysis of pre-invasive and invasive head and neck squamous carcinoma
10.1002/ijc.2910640309 · 1995
High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumours and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions
1995
The incidence of p53 mutations increases with progression of head and neck cancer
1993
Association between cigarette smoking and mutation of the p53 gene in squamous cell carcinoma of the head and neck
datacite
Confidence 0%
10.1056/nejm199503163321104 · 1995
Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer
1992
p53 mutations, protein expression and cell proliferation in squamous cell carcinomas of the head and neck
10.1038/bjc.1995.159 · 1995
Clinical implications of the p53 tumour-suppressor gene
10.1056/nejm199310283291807 · 1993
Loss of heterozygosity and p53 gene mutations in breast cancer
1994
p53 allele losses, mutation and expression in breast cancer and their relationship to clinicopathological parameters
10.1002/ijc.2910500405 · 1992
An uncertain role for p53 gene alterations in human prostate cancers
1996
Altered p53 in microdissected, metachronous, premalignant and malignant oral lesions from the same patients
10.1136/mp.48.5.m269 · 1995
Loss of 17p, mutation of the p53 gene and overexpression of p53 protein in oesophageal squamous cell carcinomas
1993
Dominant-negative mutations in yeast hit cancer hot spots
10.1073/pnas.93.9.4091 · 1996
Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumours
10.1016/0092-8674(93)90461-x · 1993
Loss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas
1991
Correlation between p53 mutations and antibody staining in breast carcinoma
10.1002/bjs.1800801118 · 1993
p53 protein detected by immunohistochemical staining is not always mutant
10.1155/1993/480686 · 1993
Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas
10.1002/path.1711710207 · 1993
The p53 and mdm-2 genes in human testicular germ cell tumours
10.1002/mc.2940120303 · 1995
Frequently elevated content of immunochemically defined wild-type p53 protein in colorectal adenomas
1993
A study of p53 protein versus point mutation in colorectal carcinoma
1994
Comparison of p53 gene mutation and protein expression in colorectal carcinoma
10.1038/bjc.1994.355 · 1994
Over-expression of p53 protein in squamous cell carcinoma of head and neck without apparent gene mutations
10.1097/00019606-199406000-00004 · 1994
The regulation of p53 function: Steiner Award Lecture
10.1002/ijc.2910570502 · 1994
p53 in tumour pathology: can we trust immunocytochemistry?
10.1002/path.1711660402 · 1992
High levels of p53 protein in UV irradiated human skin
1993
p53 immunostaining positivity is associated with reduced survival and is imperfectly correlated with gene mutations in resected non-small cell lung cancer
10.1378/chest.106.6.377s · 1994
p53 protein stability in tumour cells is not determined by mutation but is dependent on mdm2 binding
10.1038/sj.onc.1201459 · 1997
Two critical hydrophobic amino acids in the N-terminal domain of the p53 protein are required for the gain of function phenotypes of human p53 mutants
1995
Mdm2 promotes the rapid degradation of p53
10.1038/387296a0 · 1997
Regulation of p53 stability by mdm2
10.1038/387299a0 · 1997
Amplification of a gene encoding a p53-associated protein in human sarcomas
10.1038/358080a0 · 1992
The p53-mdm2 autoregulatory feedback loop
10.1101/gad.7.7a.1126 · 1993
10.1016/s0968-0004(97)01119-5
10.1016/s0968-0004(97)01119-5
A novel protein with strong homology to the tumour suppressor p53
10.1038/sj.onc.1201500 · doi-reference
Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers
10.1016/s0092-8674(00)80540-1 · doi-reference
Apoptosis in normal epithelium, premalignant and malignant lesions of the oropharynx and oral cavity: a preliminary study
10.1016/0964-1955(95)00048-8 · doi-reference
Epithelial ovarian cancer: influence of polymorphism to the glutathione S-transferase GSTM1 and GST1 loci on p53 expression
10.1038/bjc.1996.626 · doi-reference
MDM2 protein is expressed in different layers of normal human skin
10.1038/sj.onc.1200922 · doi-reference
p53 gene mutation and HPV and neck squamous cell carcinomas do not correlate with overall survival: a long term follow-up study
10.1111/j.1600-0714.1997.tb00222.x · doi-reference
Inactivation of the p53 gene by either mutation or HPV infection is extremely frequent in human oral squamous cell carcinoma cell lines
10.1016/0964-1955(94)90036-1 · doi-reference
p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3
10.1038/nm0695-570 · doi-reference
Loss of heterozygosity of p53 in oral cancers demonstrated by the polymerase chain reaction
10.1002/1097-0142(19930315)71:6<1933::aid-cncr2820710602>3.0.co;2-d · doi-reference
Number and evolutionary conservation of α and β tubulin and cytoplasmic β and γ actin genes using specific cloned cDNA probes
10.1016/0092-8674(80)90238-x · doi-reference
Primary structure polymorphism at amino acid residue 72 of human p53
10.1128/mcb.7.2.961 · doi-reference
Production of TGFα and TGFβ by cultured keratinocytes, skin and oral squamous cell carcinoma-potential autocrine regulation of normal and malignant epithelial cell proliferation
10.1038/bjc.1989.310 · doi-reference
Purification of mouse immunoglobulin heavy chain mRNA from total myeloma tumour RNA
10.1111/j.1432-1033.1980.tb06030.x · doi-reference
Allelotype of colorectal carcinoma
10.1126/science.2565047 · doi-reference
LOH at 3p correlates with a poor survival in oral squamous cell carcinoma
10.1038/bjc.1996.62 · doi-reference
Expression of TNF and the 55kDa TNF receptor in epidermis, oral mucosa, lichen planus and squamous cell carcinoma
10.1111/j.1601-0825.1996.tb00199.x · doi-reference